{"created":"2023-05-18T10:12:58.821538+00:00","id":5058,"links":{},"metadata":{"_buckets":{"deposit":"743a8168-ccf5-4791-9bc7-e77bc345c8b6"},"_deposit":{"created_by":5,"id":"5058","owners":[5],"pid":{"revision_id":0,"type":"depid","value":"5058"},"status":"published"},"_oai":{"id":"oai:yamanashi.repo.nii.ac.jp:00005058","sets":["414:444:445"]},"author_link":["24235"],"item_6_alternative_title_1":{"attribute_name":"タイトル(別表記)","attribute_value_mlt":[{"subitem_alternative_title":"2012年から2014年におけるNPS関連物質使用障害患者の臨床症状の変化、依存症専門治療病院での研究","subitem_alternative_title_language":"ja"}]},"item_6_creator_2":{"attribute_name":"著者名","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"船田, 大輔","creatorNameLang":"ja"},{"creatorName":"フナダ, ダイスケ","creatorNameLang":"ja-Kana"}],"nameIdentifiers":[{"nameIdentifier":"24235","nameIdentifierScheme":"WEKO"}]}]},"item_6_date_granted_12":{"attribute_name":"学位授与年月日","attribute_value_mlt":[{"subitem_dategranted":"2019-12-04"}]},"item_6_degree_grantor_17":{"attribute_name":"学位授与機関","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_name":"University of Yamanashi(山梨大学) "}],"subitem_degreegrantor_identifier":[{"subitem_degreegrantor_identifier_name":"13501","subitem_degreegrantor_identifier_scheme":"kakenhi"}]}]},"item_6_degree_name_13":{"attribute_name":"学位名","attribute_value_mlt":[{"subitem_degreename":" 博士(医学)  ","subitem_degreename_language":"ja"}]},"item_6_description_18":{"attribute_name":"フォーマット","attribute_value_mlt":[{"subitem_description":"application/pdf","subitem_description_language":"en","subitem_description_type":"Other"}]},"item_6_description_5":{"attribute_name":"内容","attribute_value_mlt":[{"subitem_description":"医工博4甲第283号、Neuropsychopharmacol Rep. 2019 Jun;39(2):119-129 に掲載、 https://doi.org/10.1002/npr2.12053. ","subitem_description_language":"ja","subitem_description_type":"Other"}]},"item_6_dissertation_number_16":{"attribute_name":"学位授与番号","attribute_value_mlt":[{"subitem_dissertationnumber":"甲4第283号"}]},"item_6_identifier_registration":{"attribute_name":"ID登録","attribute_value_mlt":[{"subitem_identifier_reg_text":"10.34429/00005025","subitem_identifier_reg_type":"JaLC"}]},"item_6_version_type_20":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"open access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_abf2"}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-10-13"}],"displaytype":"detail","filename":"Text_2020KD4_283.pdf","filesize":[{"value":"477.7 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"本文","objectType":"fulltext","url":"https://yamanashi.repo.nii.ac.jp/record/5058/files/Text_2020KD4_283.pdf"},"version_id":"a8ed97cf-d52d-4a21-9e59-12b27d9c8ae3"},{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-10-13"}],"displaytype":"detail","filename":"Abstract_2020KD4_283.pdf","filesize":[{"value":"213.1 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"内容要旨、審査結果要旨","objectType":"abstract","url":"https://yamanashi.repo.nii.ac.jp/record/5058/files/Abstract_2020KD4_283.pdf"},"version_id":"77c42d61-60c9-42ad-a619-1ebc76c4beee"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"doctoral thesis","resourceuri":"http://purl.org/coar/resource_type/c_db06"}]},"item_title":"Changes of clinical symptoms in patients with new psychoactive substance ( NPS )‐related disorders from fiscal year 2012 to 2014: A study in hospitals specializing in the treatment of addiction","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Changes of clinical symptoms in patients with new psychoactive substance ( NPS )‐related disorders from fiscal year 2012 to 2014: A study in hospitals specializing in the treatment of addiction","subitem_title_language":"en"}]},"item_type_id":"6","owner":"5","path":["445"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2021-10-13"},"publish_date":"2021-10-13","publish_status":"0","recid":"5058","relation_version_is_last":true,"title":["Changes of clinical symptoms in patients with new psychoactive substance ( NPS )‐related disorders from fiscal year 2012 to 2014: A study in hospitals specializing in the treatment of addiction"],"weko_creator_id":"5","weko_shared_id":-1},"updated":"2023-10-11T07:07:26.660445+00:00"}